09 October 2015

The Australian High Court ruled that the BRCA1 gene, which is associated with an increase in breast and ovarian cancer risk, is not a "patentable invention". With the landmark decision, no single company will be able to control research on the gene, or receive all the profits from testing for it.

To read more visit here.